Drug-related intimidation is a pervasive and pressing issue negatively impacting the health and well-being of individuals, families, communities and the functioning of local agencies that serve them. The aim of this evidence review is to critically appraise the national and international evidence to identify best practice, community-based responses to DRI to inform: a) DRI action points […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This evidence review describes approaches to the regulation and financing of formal home care services in four European countries. These are Germany, the Netherlands, Sweden and Scotland. It describes and compares published information on formal home care with respect to: Legislation. National standards. Staff and provider accreditation. Financing of regulation. Eligibility and needs assessment. Financing […]
This report presents an analysis of the outputs, outcomes and some emerging impacts across a range of evaluation metrics and indicators, arising from 198 HRB grants (combined value of €55 million) that completed in 2014 and 2015. The analysis presented is a snapshot at the point of end-of-grant (EOG). Further outputs, outcomes and impacts would […]
This report presents the results of a bibliometric study of peer reviewed publications fully or partially funded by the Health Research Board (HRB). The bibliometric analysis for this study was commissioned from CWTS Leiden, a world-leader in this area. The results of that analysis were compared, where possible, to a previous Bibliometric study undertaken by […]
This evidence review from the Health Research Board examines the public funding mechanisms for Assisted Reproductive Therapies (ART) in different countries. The review looks at the associated costs and benefits for the funder, provider and patient, the criteria for accessing the public funded service and the basis for these criteria in different jurisdictions.
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
